TP53 and breast carcinoma: Just recently, Olszewski et al. have demonstrated that the R248 mutational status may affect cancer cell biology, in a cell-type dependent manner, demonstrating how in breast cancer the expression of R248Q p53 decreases the motility and invasiveness [100], differently from what has been published in other tumors types [101, 102].